Shin Young Hyun
Overview
Explore the profile of Shin Young Hyun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Park B, Kim W, Suh C, Hong J, Yang D, Lee W, et al.
Leuk Lymphoma
. 2019 Jun;
60(13):3251-3257.
PMID: 31170847
This trial was designed to investigate the efficacy and toxicity of bendamustine, carboplatin, and dexamethasone (BCD) for relapsed or refractory peripheral T-cell lymphomas (PTCLs), which would be expected to exhibit...
12.
Sung P, Im C, Hyun S, Shim K, Lee J, Kong J
Korean J Intern Med
. 2017 Nov;
33(1):218-220.
PMID: 29117673
No abstract available.
13.
Choi C, Jang J, Kim J, Jo D, Lee J, Kim S, et al.
Blood Res
. 2017 Oct;
52(3):207-211.
PMID: 29043236
Background: Patients with paroxysmal nocturnal hemoglobinuria (PNH) often have concurrent aplastic anemia (AA). This study aimed to determine whether eculizumab-treated patients show clinical benefit regardless of concurrent AA. Methods: We...
14.
Lee J, Chung H, Cho H, Jang J, Kim Y, Kim S, et al.
Blood Res
. 2017 Oct;
52(3):184-192.
PMID: 29043233
Background: Isolated myeloid sarcoma (MS) is a rare extramedullary tumor mass composed of malignant myeloid precursor cells without any evidence of leukemia in the peripheral blood and bone marrow. We...
15.
Hyun S, Han S, Kim S, Jang J, Kim Y, Cho H, et al.
J Korean Med Sci
. 2016 Apr;
31(4):510-8.
PMID: 27051233
The aim of this study was to identify the risk factors associated with severe bacterial infection (SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens. A total of...
16.
Hyun S, Park S, Lee S, Kook H, Paik S, Jang I, et al.
Yonsei Med J
. 2015 Jun;
56(4):935-43.
PMID: 26069114
Purpose: Beroctocog alfa is a second generation recombinant factor VIII manufactured by removing the B-domain from factor VIII. This prospective clinical trial was conducted to evaluate the efficacy, safety, and...
17.
Bae S, Ryu H, Rhee K, Oh J, Baik S, Shim K, et al.
Growth Factors
. 2015 Feb;
33(2):71-8.
PMID: 25714612
l-ascorbic acid 2-phosphate (Asc-2P) acts as an antioxidant and a stimulator of hepatocyte growth factor (HGF) production. Previously, we reported that depletion of growth factors such as fibroblast growth factor...
18.
Shim Y, Lee K, Kim U, Suh J, Baik S, Hyun S
Blood Res
. 2014 Dec;
49(4):265-9.
PMID: 25548761
Background: Continuous infusion of factor VIII (FVIII) is a more cost-effective method for treating hemophilia A than intermittent bolus injection. However, there is currently no specific data in Korea about...
19.
Lee K, Shim Y, Jang K, Hyun S
Blood Res
. 2014 Oct;
49(3):205-7.
PMID: 25325045
No abstract available.
20.
Kim Y, Kim S, Hwang D, Jang J, Hyun S, Kim Y, et al.
Yonsei Med J
. 2014 Oct;
55(6):1568-75.
PMID: 25323893
Purpose: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of...